UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease ...

A gene therapy to correct a mutation that causes maple syrup urine disease prevented newborn death and normalized growth in a calf as well as in mice.

Financially, Monopar has a cash runway until 2026 but will need additional funds for commercialization efforts. See why I'm ...

HC Wainwright restated their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on ...

Philadelphia’s Spark Therapeutics is going through a “fundamental reorganization” by its owner, Swiss pharmaceutical giant Roche, which has written off the regional biotech leader as a financial loss ...

Cash Position: As of December 31, 2024, Fractyl had approximately $67.5 million in cash and cash equivalents. Based on ...

Fat Transport Deficiency Unveiled as Key Factor in Rare Childhood Metabolic CrisesResearchers studying a protein linked to a ...

SkylineDx’s SKY92 test with fluorescence in situ hybridisation testing led to more accurate identification of high-risk myelomas.

The long-term survival of a patient with neuroblastoma suggests the personalized cancer treatment may work for solid tumors, not just blood cancers.

In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...

A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain.

A research team led by Prof. Liu Chenli from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences (CAS) and Prof. Xiao Yichuan from the Shanghai Institute of Nutrition and ...